Obesity Independently Drives NASH and Hepatocellular Carcinoma

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2018-190
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC

Cell
BiochemistryGeneticsMolecular Biology
2018English

Hyperinsulinemia Drives Diet-Induced Obesity Independently of Brain Insulin Production

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2012English

Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma

Canadian Journal of Gastroenterology and Hepatology
MedicineHepatologyGastroenterology
2018English

Editorial: Hepatocellular Carcinoma in Non-Cirrhotic NASH-a Troubling Reality

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Oncogenic Mutations and Dysregulated Pathways in Obesity-Associated Hepatocellular Carcinoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2016English

Obesity and Hepatocellular Carcinoma in Patients Receiving Entecavir for Chronic Hepatitis B

Clinical and molecular hepatology
MedicineHepatologyMolecular Biology
2016English

Aberrant KIF20A Expression Might Independently Predict Poor Overall Survival and Recurrence-Free Survival of Hepatocellular Carcinoma

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2018English

Canagliflozin, an SGLT2 Inhibitor, Attenuates the Development of Hepatocellular Carcinoma in a Mouse Model of Human NASH

Scientific Reports
Multidisciplinary
2018English

Hepatocellular Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy